Targeting PARP-1 and DNA Damage Response Defects in Colorectal Cancer Chemotherapy with Established and Novel PARP Inhibitors

Philipp Demuth(Rheinland-Pfälzische Technische Universität Kaiserslautern-Landau), Jörg Fahrer(University of Cagliari)

Cancers

October 10, 2024

10.3390/cancers16203441

Cited by 10

Related Papers

AKT2 suppresses pro-survival autophagy triggered by DNA double-strand breaks in colorectal cancer cells

|Cell Death and Disease|2017|45

DNA damage response curtails detrimental replication stress and chromosomal instability induced by the dietary carcinogen PhIP

|Nucleic Acids Research|2016|38

Natural Merosesquiterpenes Activate the DNA Damage Response via DNA Strand Break Formation and Trigger Apoptotic Cell Death in p53-Wild-Type and Mutant Colorectal Cancer

|Cancers|2021|16

Potency ranking of pyrrolizidine alkaloids in metabolically competent human liver cancer cells and primary human hepatocytes using a genotoxicity test battery

|Archives of Toxicology|2023|14

OCT1-dependent uptake of structurally diverse pyrrolizidine alkaloids in human liver cells is crucial for their genotoxic and cytotoxic effects

|Archives of Toxicology|2023|6